Document is current
Any future updates will be listed below
-
Authors
Catanzaro, Nicholas J.
Wu, Ziyan
Fan, Chengcheng https://orcid.org/0000-0003-4213-5758
Jefferson, Victoria https://orcid.org/0000-0003-3056-1813
Abdelgadir, Anfal
Schäfer, Alexandra https://orcid.org/0000-0002-4760-4923
Yount, Boyd L.
Bjorkman, Pamela J. https://orcid.org/0000-0002-2277-3990
Baric, Ralph https://orcid.org/0000-0001-6827-8701
Letko, Michael https://orcid.org/0000-0002-7640-2861
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AI167966)
- License Information
-
More Information
Article History
Received: 17 December 2024
Accepted: 20 May 2025
First Online: 28 May 2025
Competing interests
: RSB is a member of advisory boards for VaxArt, Takeda and Invivyd, and has collaborative projects with Gilead, J&J, and Hillevax, focused on unrelated projects. The remaining authors compare no competing interests.
